Move Aside, Moderna: This mRNA Stock Is Sitting on a Cash Pile and a Deep Cancer Pipeline

Moderna isn't the only mRNA biotech stock that could deliver big gains for investors. BioNTech(NASDAQ: BNTX) has billions in ...

Moderna is now worth more than 3X as much as BioNTech. Which biotech stock is the smarter pick?

Is bigger always better? Not necessarily.

Which Is the Bigger Story for BioNTech -- Its Colorectal Cancer Vaccine Setback or the Lung Cancer Clinical Success?

The company is looking to prove it can achieve significant success outside the coronavirus market.
BioSpace

BioNTech faces 3rd mRNA setback as head and neck cancer therapy fails to improve survival

While BNT113 failed to improve progression-free survival in patients with a type of head and neck cancer during a Phase 3 ...

BioNTech's mRNA cancer therapy misses first goal in head and neck trial

Oct 13 (Reuters) - BioNTech said on Tuesday its experimental mRNA cancer immunotherapy failed to meet the first main goal of ...
BioPharma Dive

BioNTech mRNA cancer immunotherapy misses first objective in key study

An early data check showed the shot didn’t delay tumor progression in a form of head and neck cancer, though BioNTech is ...
24/7 Wall St.

Moderna Tumbles 10% as Profit Taking Hits Cancer Vaccine Rally; BioNTech Eases, Pfizer Stays Put

Profit taking is hitting one of biotech’s hottest trades, and the selling is landing heaviest on the stock that ran the ...
PR Newswire

BioNTech Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into BioNTech (BNTX)

Every $10,000 held in BioNTech SE (NASDAQ: BNTX) shrank by roughly $713 after the Company announced that its Phase 2/3 ...

BioNTech Says Cancer Treatment Didn’t Help in Early Analysis

BioNTech SE said an experimental cancer drug didn’t help volunteers with a form of head and neck carcinoma live longer ...

Moderna Rallies 6% as Money Rotates Into Healthcare; BioNTech and Pfizer Edge Higher

Healthcare is drawing fresh buying as money moves away from the market’s popular technology trade, and one messenger RNA ...

Could a New Vaccine Formula XFG Give Pfizer (PFE) and BioNTech (BNTX) a Post-Pandemic Revenue Boost?

Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) announced on August 27 that the U.S. FDA has approved the supplemental Biologics License Application for their 2026–2027 COVID-19 vaccine formula, ...
RTTNews

BioNTech's BNT113 Misses Progression-Free Survival Endpoint In Phase 3 Head And Neck Cancer Trial

HPV16-positive HNSCC represents a subset of head and neck cancers, and treatment options remain limited for patients with recurrent or metastatic disease. BNT113 received Fast Track Designation from ...